FDA Releases Key Guidance Updates

The U.S. Food and Drug Administration (FDA) has recently published several guidance documents and policy updates that clarify and modernize regulatory expectations across digital health, medical devices, real-world evidence, and clinical trial design.

Below you can find a list of the updated documents with the respective links:

US FDA Guidance: Clinical Decision Support Software (Jan 2026)

https://www.fda.gov/regulatory-information/search-fda-guidance-documents/clinical-decision-support-software

US FDA Guidance: Low risk wellness devices (Jan 2026)

https://www.fda.gov/regulatory-information/search-fda-guidance-documents/general-wellness-policy-low-risk-devices

US FDA Guidance: Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices (Dec 2025)

https://www.fda.gov/regulatory-information/search-fda-guidance-documents/use-real-world-evidence-support-regulatory-decision-making-medical-devices

US FDA Draft Guidance: Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products (Jan 2026)

https://www.fda.gov/regulatory-information/search-fda-guidance-documents/use-bayesian-methodology-clinical-trials-drug-and-biological-products